Barclays »

Astria Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $780k 107k 7.28
2025-06-30 $630k 118k 5.36
2025-03-31 $389k 73k 5.35
2024-12-31 $875k 98k 8.95
2024-09-30 $1.0M 93k 11.01
2024-06-30 $494k 54k 9.09
2024-03-31 $1.9M 135k 14.08
2023-12-31 $379k 49k 7.67
2023-09-30 $62k 8.4k 7.37
2023-06-30 $75k 9.0k 8.32
2023-03-31 $439k 33k 13.30